what is glp 1 agonist GLP-1 Agonists Discovery of GLP-1–Based Drugs for

35-39.9: 0.61, 0.41 to 0.91

It produces more modest results than semaglutide or tirzepatide, typically around 8 percent body weight loss, but it was the first GLP-1 to receive FDA approval specifically for weight management and remains a viable option for patients who prefer a shorter-acting medication or who experience intolerable side effects on the more potent formulations

10.1016/j.molmet.2021.101351 16 DuarteA

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

Drugs that you should not take with Saxenda include: Other glucagon-like peptide-1 (GLP-1) agonists

June 28, 2024: Study Reveals Potential Bone Density Reduction with GLP-1 Treatment In a recent study, Simon Jensen, Ph.D., and others found that GLP-1 treatment, without exercise, could lead to reduced bone density